Advances in magnetic resonance neuroimaging techniques in the evaluation of neonatal encephalopathy

Topics in Magnetic Resonance Imaging

Volumn 18, Issue 1, 2007, Pages 3-29

  Panigrahy, Ashok ^a,b   Blüml, Stefan ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Diffusion tensor imaging; MR spectroscopy; Neonatal encephalopathy; Perinatal white matter injury

Indexed keywords

ARTICLE; BIRTH INJURY; BRAIN DEVELOPMENT; BRAIN DISEASE; BRAIN INJURY; BRAIN ISCHEMIA; DIAGNOSTIC VALUE; DIFFUSION TENSOR IMAGING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; INCUBATOR; METABOLIC ENCEPHALOPATHY; NEONATAL HEMORRHAGE; NEUROIMAGING; NEWBORN; NEWBORN INFECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; WHITE MATTER;

ANISOTROPY; BRAIN DISEASES; BRAIN INJURIES; EQUIPMENT DESIGN; HUMANS; INCUBATORS, INFANT; INFANT, NEWBORN; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 34347334535     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/RMR.0b013e318093e6c7     Document Type: Article

References (126)

1. Ferriero DM. Neonatal brain injury. N Engl J Med. 2004;351:1985-1995.
2. Bluml S, Friedlich P, Erberich S, et al. MR imaging of newborns by using an MR-compatible incubator with integrated radiofrequency coils: initial experience. Radiology. 2004;231:594-601.
3. Dumoulin CL, Rohling KW, Piel JE, et al. Magnetic resonance imaging compatible neonate incubator. Concepts Magn Reson. 2002;15:117-128.
4. Forbes KPN, Pipe JG, Bird CR, et al. PROPELLER MRI: clinical testing of a novel technique for quantification and compensation of head motion. J Magn Reson Imaging. 2001;14:215-222.
5. Beaulieu C. The basis of anisotropic water diffusion in the nervous system - a technical review. NMR Biomed. 2002;15:435-455.
6. Le Bihan D, Mangin JF, Poupon C, et al. Diffusion tensor imaging: concepts and applications. J Magn Reson Imaging. 2001;13:534-546.
7. Conturo TE, McKinstry RC, Akbudah E, et al. Encoding of anisotropic diffusion with tetrahedral gradients: a general mathematical diffusion formalism and experimental results. Magn Reson Med. 1996;35:399-412.
8. Basser PJ, Jones DK. Diffusion-tensor MRI: theory, experimental design and data analysis - a technical review. NMR Biomed. 2002;15:456-467.
9. Wimberger DM, Roberts TP, Barkovich AJ, et al. Identification of "premyelination" by diffusion-weighted MRI. J Comput Assist Tomogr. 1995;19:23-33.
10. Prayer D, Barkovich AJ, Kirschner DA, et al. Visualization of nonstructural changes in early white matter development on diffusion- premyelination anisotropy. AJNR Am J Neuroradiol. 2001;22:1572-1576.
11. Shimony JS, McKinstry RC, Akbudak E, et al. Quantitative diffusion-tensor anisotropy imaging: normative human data and anatomic analysis. Radiology. 1999;12:770-784.
12. Neil JJ, Shiran SI, McKinstry RC, et al. Normal brain in human newborns: apparent diffusion coefficient and diffusion anisotropy measured by using diffusion tensor MR imaging. Radiology. 1998;209:57-66.
13. Partridge SC, Mukherjee P, Hentry RG, et al. Diffusion tensor imaging: serial quantitation of white matter tract maturity in premature newborns. Neuroimage. 2004;22:1302-1314.
14. Mukherjee P, Miller JH, Shimony JS, et al. Normal brain maturation during childhood: developmental trends characterized with diffusion-tensor MR imaging. Radiology. 2001;221:349-358.
15. Mukherjee P, Miller JH, Shimony JS, et al. Diffusion-tensor MR imaging of gray and white matter development during normal human brain maturation. AJNR Am J Neuroradiol. 2002;23:1445-1456.
16. Miller JH, Mckinstry RC, Philip JC, et al. Diffusion-tensor MR imaging of normal brain maturation: a guide to structural development and myelination. AJR Am J Roentgenol. 2003;180:851-859.
17. Mukherjee P, Mckinstry RC. Diffusion tensor imaging and tractography of human brain development. In: Castillo M, Mukherji SK, eds. Neuroimaging Clinics of North America. Vol. 16. No. 1. Philadelphia, PA: WB Saunders; 2006:19-43.
18. Pajevic S, Pierpaoli C. Color schemes to represent the orientation of anisotropic tissues from diffusion tensor data: application to white matter fiber tract mapping in the human brain. Magn Reson Med. 1999;42:526-540.
19. Conturo TE, Lri NF, Cull TS, et al. Tracking neuronal fiber pathways in the living human brain. Proc Natl Acad Sci U S A. 1999;96:10422-10427.
20. Mori S, Crain BJ, Chacko VP, et al. Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Ann Neurol. 1999;45:265-269.
21. Basser PJ, Pajevic S, Pierpaoli C, et al. In vivo fiber tractography using DT-MRI data. Magn Reson Med. 2000;44:625-632.
22. Huppi PS, Maier SE, Peled S, et al. Microstructural development of human newborn cerebral white matter assessed in vivo by diffusion tensor magnetic resonance imaging. Pediatr Res. 1998;44:584-590.
23. Barkovich AJ. Pediatric Neuroimaging. 4th ed. Philadelphia, PA: Lippincott; 2005.
24. Yakovlev PI, Loecours AR. The myelogenic cycles of regional maturation of the brain. In: Minkowski A, ed. Regional Development of the Brain in Early Life. Oxford, UK: Blackwell; 1967:3-70.
25. Richardson EP Jr. Myelination in the human central nervous system. In: Haymaker W, Adams RD, eds. Histology and Histopathology of the Nervous System. Springfield, IL: Charles C. Thomas Publishers; 1982:146-173.
26. Kinney HC, Brody BA, Kloman AS, et al. Sequence of central nervous system myelination in human infancy. II. Patterns of myelination in autopsied infants. J Neuropathol Exp Neurol. 1988;47:217-234.
27. Evans AC, for the Brain Development Cooperative Group. The NIH MRI Study of Normal Brain Development. Neuroimage. 2006;30:184-202.
28. McKinstry RC, Brain Development Cooperative Group. The NIH MRI Study of Normal Brain Development. In: Proceedings of the Thirteenth Annual Meeting of the International Society for Magnetic Resonance in Medicine. Miami, FL: International Society for Magnetic Resonance in Medicine; 2005.
29. Lien YH, Shapiro JI, Chan L. Effects of hypernatremia on organic brain osmoles. J Clin Invest. 1990;85:1427-1435.
30. Videen JS. Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study [see comments]. J Clin Invest. 1995;95:788-793.
31. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 1993;30:672-679.
32. Erecinska M, Silver IA. Metabolism and role of glutamate in mammalian brain. Prog Neurobiol. 1990;35:245-296.
33. Daikhin Y, Yudkoff M. Compartmentation of brain glutamate metabolism in neurons and glia. J Nutr. 2000;130(4S suppl):1026S-1031S.
34. Kreis R. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy [see comments]. Radiology. 1992;182:19-27.
35. Seymour KJ, Bluml S, Sutherling J, et al. Identification of cerebral acetone by 1H-MRS in patients with epilepsy controlled by ketogenic diet. Magma. 1999;8:33-42.
36. Ball WS Jr, Holland SK. Perfusion imaging in the pediatric patient. Magn Reson Imaging Clin N Am. 2001;9:207-230.
37. Huisman TA, Sorensen AG. Perfusion-weighted magnetic resonance imaging of the brain: techniques and application in children. Eur Radiol. 2004;14:59-72.
38. Ostergaard L, Weisskoff RM, Chelser DA, et al. High-resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis. Magn Reson Med. 1996;36:715-725.
39. Detre JA, Aslop DC. Perfusion fMRI with arterial spin labeling based perfusion imaging techniques for MRI. In: Moonen CTW, Bandetti PA, eds. Functional MRI. Heidelberg, Germany: Springer-Verlag; 1999:47-62.
40. Detre JA, Leigh JS, Williams DS, et al. Perfusion imaging. Magn Reson Med. 1992;23:37-45.
41. Calamante F, Thomas DL, Pell GS, et al. Measuring cerebral blood flow using magnetic resonance imaging techniques. J Cereb Blood Flow Metab. 1999;19:701-735.
42. Wong EC, Buxton RB, Frank LR. Quantitative imaging of perfusion using a single subtraction (QUIPSS and QUIPSS II). Magn Reson Med. 1998;39:702-708.
43. Buxton RB, Frank LR, Wong EC, et al. A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn Reson Med. 1998;40:383-396.
44. Tanner SF, Cornette L, Ramenghi LA, et al. Cerebral perfusion in infants and neonates: preliminary results obtained using dynamic susceptibility contrast enhanced magnetic resonance imaging. Arch Dis Child Fetal Neonatal Ed. 2003;88:F525-F530.
45. Miranda MJ, Olofsson K, Sidaros K. Noninvasive measurements of regional cerebral perfusion in preterm and term neonates by magnetic resonance arterial spin labeling. Pediatr Res. 2006;60:359-363.
46. Ogawa S, Tank DW, Menon R, et al. Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging. Proc Natl Acad Sci U S A. 1992;89:5951-5955.
47. Kwong KK, Belliveau JW, Chesler DA, et al. Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci U S A. 1992;89:5675-5679.
48. Seghier ML, Lazeyras F, Huppi PS. Functional MRI of the newborn. Semin Fetal Neonatal Med. 2006;11:479-488.
49. Erberich SG, Friedlich P, Seri I, et al. Functional MRI in neonates using neonatal head coil and MR compatible incubator. Neuroimage. 2003;20:683-692.
50. Erberich GS, Panigrahy A, Friedlich P, et al. Somatosensory lateralization in the newborn brain. Neuroimage. 2006;29:155-161.
51. Dehaene-Lambertz G, Dehaene S, Hertz-Pannier L. Functional neuroimaging of speech perception in the infants. Science. 2002;298:2013-2015.
52. Uggetti C, Egitto ME, Fazzi E, et al. Cerebral visual impaired in periventricular leukomalacia: MR correlation. AJNR Am J Neuroradiol. 1996;17:979-985.
53. Jacobson L, Ek U, Fernell E, et al. Visual impairment in preterm children with periventricular leukomalacia - visual, cognitive, and neuropaediatric characteristics related to cerebral imaging. Dev Med Child Neurol. 1996;38:724-735.
54. Volpe JJ. Cerebral white matter injury of the premature infant - more common than you think. Pediatrics. 2003;112:176-180.
55. Banker BQ, Larroche JC. Periventricular leukomalacia of infancy. Arch Neurol. 1962;7:386-410.
56. Leviton A, Gilles FH. An epidemiologic study of perinatal elencephalic leucoencephalopathy in an autopsy population. J Neurol Sci. 1973;18:53-66.
57. Gilles FH, Leviton A, Dooling EC. The Developing Human Brain. Growth and Epidemiologic Neuropathology. Littleton, MA: Wright-PSG; 1983.
58. Volpe JJ. Neurology of the Newborn. 4th ed. Philadelphia, PA: WB Saunders; 2000.
59. Wood NS, Marlow N, Costeloe K, et al. Neurologic and developmental disability after extremely preterm birth. N Engl J Med. 2000;343:378-384.
60. Kinney HC. The near-term (late preterm) human brain and risk for periventricular leukomalacia: a review. Semin Perinatol. 2006;30:81-88.
61. Back SA. Perinatal white matter injury: the changing spectrum of pathology and emerging insights into pathogenetic mechanisms. Ment Retard Dev Disavil Res Rev. 2006;12:129-140.
62. Inder TE, Wells SJ, Mogridge NB, et al. Defining the nature of cerebral abnormalities in the premature infant: qualitative magnetic resonance imaging study. J Pediatr. 2003;143:171-179.
63. Wu YW, Colford JM Jr. Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA. 2000;284:1417-1424.
64. Kinney HC, Armstrong DD. Perinatal neuropathology. In: Graham DI, Lantos PI, eds. Greenfield's Neuropathology. London, UK: Arnold; 2002:557-559.
65. Kadhim H, Tabarki B, Verellen G, et al. Inflammatory cytokines in the pathogenesis of periventricular leukomalacia. Neurology. 2001;56:1278-1284.
66. Follett PL, Rosenberg PA, Volpe JJ, et al. NBQX attenuates excitotoxic injury in developing white matter. J Neurosci. 2000;20:9235-9241.
67. Back SA, Han BE, Luo NL, et al. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci. 2002;22:455-463.
68. Gilles FH, Leviton A, Kerr CS. Endotoxin leucoencephalopathy in the telencephalon of the newborn kitten. J Neurol Sci. 1976;27:183-191.
69. Back SA, Gan X, Li Y, et al. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced cell death caused by glutathione depletion. J Neurosci. 1998;18:6241-6253.
70. Inder T, Anderson N, Spencer C, et al. White matter injury in the premature infant: a comparison between serial cranial sonographic and MR finding at term. AJNR Am J Neuroradiol. 2003;24:805-809.
71. Miller S, Cozzio C, Goldstein R, et al. Comparing the diagnosis of white matter injury in premature newborns with serial MR imaging and transfontanel ultrasonography findings. AJNR Am J Neuroradiol. 2003;241:1661-1669.
72. Nelson MD Jr, Gonzalez-Gomez I, Gilles FH. The search for human telencephalic ventriculofugal arteries. Am J Neuroradiol. 1991;12:215-222.
73. Childs AM, Ramenghi LA, Evans DJ, et al. MR features of developing periventricular white matter in preterm infants: evidence of glial cell migration. AJNR Am J Neuroradiol. 1998;19:971-973.
74. Miller SP, Vigneron DB, Henry RG, et al. Serial quantitative diffusion tensor MRI of the premature brain: development in newborns with and without injury. J Magn Reson Imaging. 2002;16:621-632.
75. Inder T, Huppi PS, Zientara GP, et al. Early detection of periventricular leukomalacia by diffusion-weighted magnetic resonance imaging techniques. J Pediatr. 1999;134:631-634.
76. Counsell SJ, Allsop JM, Harrison MC, et al. Diffusion-weighted imaging of the brain in preterm infants with focal and diffuse white matter abnormality. Pediatrics. 2003;112(1 Pt 1):1-7.
77. Miller SP, Ferriero DM, Leonard C, et al. Early brain injury in premature newborns detected with magnetic resonance imaging is associated with adverse early neurodevelopmental outcome. J Pediatr. 2005;147:609-616.
78. Woodward LJ, Anderson PJ, Austin NC, et al. Neonatal MRI to predict neurodevelopmental outcomes in preterm infants. N Engl J Med. 2006;355:685-694.
79. Kinney HC, Haynes RL, Folkerth RD. White matter lesions in the prenatal period. In: Golden JA, Harding BN, eds. Developmental Neuropathology. Basel, Switzerland: International Society of Neuropathology; 2004:156-170.
80. Kreis R, Hofmann L, Kuhlmann B, et al. Brain metabolite composition during early human brain development as measured by quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med. 2002;48:949-958.
81. Kreis R, Ernst T, Ross BD. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med. 1993;30:424-437.
82. Ernst T, Kreis R, Ross BD. Absolute quantitation of water and metabolites in the human brain. I. Compartments and water. J Magn Reson. 1993;102:1-8.
83. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 1993;30:672-679.
84. Shu SK, Ashwal S, Hosouser BA, et al. Prognostic value of 1-H MRS in perinatal CNS insults. Pediatr Neurol. 1997;17:309-318.
85. Penrice J, Cady EB, Lorek A, et al. Proton magnetic resonance spectroscopy of the brain in normal and term infants and early changes after perinatal hypoxia-ischemia. Pediatr Res. 1996;40:6-14.
86. Hanrahan JD, Sargentoni J, Azzopardi D, et al. Cerebral metabolism within 18 hours of birth asphyxia: a proton magnetic resonance spectroscopy study. Pediatr Res. 1996;39:584-590.
87. Leth H, Toft PB, Peitersen B, et al. Use of brain lactate levels to predict outcome after perinatal asphyxia. Acta Paediatr. 1996;85:859-864.
88. Holshouser BA, Ashwal S, Luh GY, et al. Proton MR spectroscopy after acute central nervous system injury: outcome prediction in neonates, infants, and children. Radiology. 1997;202:487-496.
89. Groenendaal F, Veenhoven RH, van der Grond J, et al. Cerebral lactate and N-acetyl-aspertate/choline ratios in asphyxiated full term neonates demonstrated in-vivo using proton magnetic resonance spectroscopy. Pediatr Res. 1994;35:148-151.
90. Huppi PS, Posse S, Lazeyras F, et al. Magnetic resonance in preterm and term newborns: H-1 spectroscopy in developing brain. Pediatr Res. 1991;30:574-578.
91. Cheong JLY, Cady EB, Penrice J, et al. Proton MR spectroscopy in neonates with perinatal cerebral hypoxic-ischemic injury: metabolite peak-area ratios, relaxation times, and absolute concentrations. AJNR Am J Neuroradiol. 2006;27:1546-1554.
92. Moorcraft J, Bolas NM, Ives NK, et al. Spatially localized magnetic resonance spectroscopy of the brains of normal and asphyxiated newborns. Pediatrics. 1991;87:273-282.
93. Peden CJ, Cowan FM, Bryant, et al. Proton MR spectroscopy of the brain in infants. J Comput Assist Tomogr. 1990;14:886-894.
94. Barkovich AJ, Baranski K, Vigneron DB, et al. Proton MR spectroscopy for the evaluation of asphyxiated term neonates. AJNR Am J Neuroradiol. 1999;20:1399-1405.
95. Vigneron DB, Barkovich AJ, Noworolski SM, et al. Three-dimensional proton MR spectroscopic imaging of premature and term neonates. AJNR Am J Neuroradiol. 2001;22:1424-1433.
96. Kreis R, Hofmann L, Kuhlmann B, et al. Brain metabolite composition during early human brain development as measured by quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med. 2002;48:949-958.
97. Kinney HC, Panigrahy A, Newberger J, et al. Hypoxic-ischemic brain injury in infants with congenital heart disease dying after cardiopulmonary bypass surgery. Acta Neuropathol (Berl). 2005;110:563-578.
98. Licht DJ, Wang J, Silvestre DW, et al. Preoperative cerebral blood flow is diminished in neonates with severe congenital heart defects. J Thorac Cadiovasc Surg. 2004;128:841-849.
99. Barkovich AJ, Westmark KD, Bedi HS, et al. Proton spectroscopy and diffusion imaging on the first day of life after perinatal asphyxia: preliminary report. AJNR Am J Neuroradiol. 2001;22:1786-1794.
100. Barkovich AJ, Miller SP, Bartha A, et al. MR imaging, MR spectroscopy, and diffusion tensor imaging of sequential studies in neonates with encephalopathy. AJNR Am J Neuroradiol. 2006;27:533-547.
101. Grant PE, Yu D. Acute injury to the immature brain with hypoxia with or without hypoperfusion. Radiol Clin N Am. 2006;44:63-77.
102. Wolf MJ, Wolf B, Beunen G, et al. Neurodevelopmental outcome at 1 year in Zimbabwean neonates with extreme hyperbilirubinaemia. Eur J Pediatr. 1999;158:111-114.
103. Kinnala A, Rikalainen H, Lapinleimu H, et al. Cerebral magnetic resonance imaging and ultrasonography findings after neonatal hypoglycemia. Pediatrics. 1999;103:724-729
104. Barkovich AJ. Toxic and metabolic brain disorders. In: Barkovich AJ, ed. Pediatric Neuroimaging. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:76-189.
105. Cecil K. MR spectroscopy of metabolic disorders. In: Castillo M, Mukherji SK, eds. Neuroimaging Clinics of North America. Vol. 16. No. 1. Philadelphia, PA: WB Saunders; 2006:87-116.
106. van der Knaap MS, Valk J. Magnetic Resonance of Myelin, Myelination and Myelin Disorders. 2nd ed. Berlin, Germany: Springer; 1995.
107. Enns GM, Barkovich AJ, Rosenblatt DS, et al. Progressive neurological deterioration and MRI changes in cblC methylmalonic academia treated with hydroxocoblamin. J Inherit Metab Dis. 1999;22:599-607.
108. Jan W, Zimmerman RA, Wang ZJ, et al. MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation. Neuroradiology. 2003;45:393-399.
109. Cavalleri F, Bernardi A, Burlina A, et al. Diffusion-weighted MRI of maple syrup urine disease encephalopathy. Neuroradiology. 2002;44:499-502.
110. Takanashi J, Barkovich A, Cheng S, et al. Brain MR imaging in acute hyperammonemic encephalopathy arising from late-onset ornithine transcarbamylase deficiency. AJNR Am J Neuroradiol. 2003;24:390-393.
111. Choi C-G, Yoo HW. Localized proton MR spectroscopy in infants with urea cycle defect. AJNR Am J Neuroradiol. 2001;22:834-837.
112. Bianchi MC, Tosetti M, Battini R, et al. Proton MR spectroscopy of mitochondrial diseases: analysis of brain metabolic abnormalities and their possible diagnostic relevance. AJNR Am J Neurolradiol. 2003;24:1958-1966.
113. Cross JH, Connelly A, Gadian DG, et al. Clinical diversity of pyruvate dehydrogenase deficiency. Pediatr Neurol. 1994;10:276-283.
114. Zand DJ, Simon EM, Pulitzer SB, et al. In vivo pyruvate detected by MR spectroscopy in neonatal pyruvate dehydrogease deficiency. AJNR Am J Neuroradiol. 2003;24:1471-1474.
115. Bruhn H, Kruse B, Korenke GC, et al. Proton NMR spectroscopy of cerebral metabolic alterations in infantile peroxisomal disorders. J Comput Assist Tomogr. 1992;16:335-344.
116. Volpe JJ. Hypoxic-ischemic encephalopathy: clinical aspects. In: Volpe JJ, ed. Neurology of the Newborn. 3rd ed. Philadelphia, PA: WB Saunders; 1995:314-369.
117. Papile LA, Brunstein J, Burstein R, et al. Incidence and evolution of subpendymal and intraventricular hemorrhage: A study of infants with birth weights less than 1500 gm. J Pediatr. 1978;92:529-534.
118. Zuerrer M, Martin E, Bltshauser E. MR Imaging of intracranial hemorrhage in neonates and infants at 1.5 Tesla. Neuroradiology. 1991;33:223-229.
119. Gould SJ, Howard S, Hope PL, et al. Periventricular intraparenchymal cerebral hemorrhage in preterm infants: the role of venous infarction. J Pathol. 1987;151:197-202.
120. Klein JO. Bacterial sepsis and meningitis. In: Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn Infant. 5th ed. Philadelphia, PA: WB Saunders; 1995:943-998.
121. Bale JF, Murph JR. Congenital infections of the nervous system. Pediatr Clin North Am. 1992;39:669.
122. Barkovich AJ, Lindan CE. Congenital cytomegalovirus infection of the brain: imaging analysis and embryologic considerations. AJNR Am J Neuroradiol. 1994;15:703-715.
123. Dublin AB, Merten DF. Computed tomography in the evaluation of herpes simplex encephalitis. Radiology. 1997;125:133-134.
124. Weisman LE, Stoll BJ, Creusss DF, et al. Early onset group B streptococcal sepsis: a current assessment. J Pediatr. 1992;121:428-433.
125. Smith H, Congdon P. Neonatal systemic candidiasis. Arch Dis Child. 1985;60:365.
126. Iffy L, Varadi V, Jakobovits A. Common intrapartum denominators of shoulder dystocia related birth injuries. Zentralbl Gynakol. 1994;116:33-37.